Joel Habener
Joel Habener is a Professor of Medicine at Harvard Medical School who has done fundamental studies on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). For his discoveries, he was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[1] He was elected to the National Academy of Sciences in 2020.[2] In 2021 he was awarded the Canada Gairdner International Award.[3]
References[]
- ^ "Prize Recipients | Warren Alpert Foundation Prize". warrenalpert.org.
- ^ "2020 NAS Election". www.nasonline.org.
- ^ Canada Gairdner International Award 2021
| hide Authority control  | |
|---|---|
| General |
|
| National libraries | |
   | This biographical article related to a physician in the United States is a stub. You can help Wikipedia by . |
Categories:
- Harvard Medical School staff
- Medical researchers
- Members of the United States National Academy of Sciences
- Living people
- American physician stubs